The Affiliated Hospital of Stomatology, School of Stomatology, Zhejiang University School of Medicine, and Key Laboratory of Oral Biomedical Research of Zhejiang Province, Hangzhou, Zhejiang, China.
Clin Oral Implants Res. 2021 Feb;32(2):180-191. doi: 10.1111/clr.13688. Epub 2020 Dec 26.
To compare clinical and radiographic outcomes between transcrestal sinus floor elevation (TSFE) and lateral sinus floor elevation (LSFE) approaches of simultaneous implant placement in atrophic maxilla.
Patients with a residual bone height (RBH) ≤6 mm were enrolled and randomly assigned to TSFE and LSFE groups. Patients in both groups simultaneously underwent sinus floor elevation with bovine-derived xenograft and implant placement. Clinical and radiographic results were evaluated immediately after surgery and after 6, 12, 18, and 24 months. The endo-sinus bone gain (ESBG), apical implant bone height (ABH), endo-sinus bone-implant contact rate (EBICR), and crestal bone level (CBL) were assessed using panoramic radiographs.
Forty-one implants (TSFE: 21, LSFE: 20) were placed in cases with a mean RBH of 3.77 ± 1.16 mm. All implants obtained clinical success and satisfactory ESBG at 24 months. No significant differences were found in ESBG and ABH between two groups immediately after surgery, but LSFE group showed significantly higher values than TSFE group thereafter. Grafts in TSFE group reached stability 6 months earlier than that in LSFE group. In both groups, EBICR was almost 100%, and CBL showed no detectable changes.
LSFE can achieve higher ESBG 2 years after surgery. Otherwise, TSFE could be an alternative to LSFE, when the access for lateral window preparation is limited. Both approaches were highly predictable for RBH ≤6 mm during 24-month observation period for the implants placed simultaneously.
比较经牙槽嵴窦底提升(TSFE)和外侧窦底提升(LSFE)两种方法在牙槽嵴萎缩的上颌骨同期种植中的临床和影像学效果。
纳入牙槽骨剩余高度(RBH)≤6mm的患者,并随机分为 TSFE 和 LSFE 两组。两组患者均同期接受牛源性异种骨提升窦底和种植体植入。术后即刻、术后 6、12、18 和 24 个月对临床和影像学结果进行评估。采用全景片评估窦内骨增量(ESBG)、种植体根尖骨高度(ABH)、窦内骨-种植体接触率(EBICR)和牙槽嵴顶骨水平(CBL)。
41 枚种植体(TSFE:21 枚,LSFE:20 枚)植入 RBH 均值为 3.77±1.16mm 的患者中。所有种植体均获得临床成功,术后 24 个月时 ESBG 满意。术后即刻,两组间 ESBG 和 ABH 无显著差异,但此后 LSFE 组值高于 TSFE 组。TSFE 组的移植物 6 个月时达到稳定,早于 LSFE 组。两组的 EBICR 几乎为 100%,CBL 无明显变化。
LSFE 术后 2 年可获得更高的 ESBG。当外侧开窗术的入路有限时,TSFE 可作为 LSFE 的替代方法。在同期种植的 24 个月观察期内,两种方法对 RBH≤6mm 的种植体均具有高度可预测性。